Loading clinical trials...
Loading clinical trials...
This non-interventional study of real-life clinical practice strategies for long-term relapse control in patients with psoriasis vulgaris is planned to enroll 650 adult patients from 60-100 Russian de...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
LEO Pharma
NCT06398106 · Psoriasis Vulgaris
NCT07320872 · Psoriasis Vulgaris
NCT04080635 · Psoriasis Vulgaris
NCT04306315 · Psoriasis Vulgaris
NCT04340076 · Psoriasis, Psoriasis Vulgaris
The State Autonomous Foundation of Public Health "Republic Clinical Dermatovenereological Dispensary" of the Republic of Tatarstan
Kazan', Tatarstan Republic
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions